Tags: MDMAecstasyPTSD therapyhumourpharma
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | 3 closely watched drugs that failed in the clinic - 10 days ago An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped? - 3 months ago Neuro drugs are still faltering, despite rising investment - 5 months ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago | |
| 2 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | God bless, Americas! - about 1 month ago | |
| 3 | Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom | ||
| 4 | Jason Mast STAT News Writing about science, medicine. | ||
| 5 | John Wilkerson STAT News STAT Washington correspondent. | ||
| 6 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | A tough week for MDMA-assisted psychotherapy - 5 months ago The latest updates on cancer research from the weekend - 9 months ago How resurrecting extinct species might impact medicine - 9 months ago | |
| 7 | Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. | ||
| 8 | Katrina Krämer Nature Science journalist. Cambridge, UK | ||
| 9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | The hunt for the brain’s biomarkers - 6 months ago 4 offbeat biotechs making a splash in the life sciences - 8 months ago | |
| 10 | Clare Wilson New Scientist Science news source. Worldwide |